We are situated within the Karolinska Institute campus in Stockholm, Sweden.
Our address for visits, post, and deliveries is:
Elypta AB, Scheeles väg 3, 171 65 Solna, Sweden
Large deliveries agreed to beforehand in need of a loading bay (e.g. on pallets) can be delivered to:
Retzius Väg 2, 171 65, Solna, Sweden
Elypta is a Swedish diagnostic company focused on developing new biomarkers for cancer risk-stratification. The company pursues profiling of glycosaminoglycans (GAGome) as a new category of dynamic biological risk markers with the aim to enable an expansion of cancer screening and prevention. Elypta’s leading indication is lung cancer risk with a broader program targeting multi-cancer risk applications as well as research use in other disease areas.
.svg)
ISO 13485:2016 certified for Design, development and manufacture of in vitro diagnostic test kits and software for the measurement and interpretation of glycosaminoglycans (GAGs) in human biofluids
